Squamous cell carcinoma antigen as a biomarker for penile cancer

BJU International

Volumn 95, Issue 4, 2005, Pages 478-479

  Kommu, Sashi ^a   Hadway, Paul ^a   Watkin, Nick ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SQUAMOUS CELL CARCINOMA ANTIGEN;

CANCER INCIDENCE; DISEASE MARKER; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; NOTE; PENIS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; RADIOIMMUNOASSAY; URINARY TRACT CANCER;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; HUMANS; MALE; PENILE NEOPLASMS; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 14644432533     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05378.x     Document Type: Note

References (15)

1. Solsona E, Algaba F, Horenblas S, Pizzocaro G, Windahl T. EAU guidelines on penile cancer. Eur Urol 2004; 46: 1-8
2. Solsona E, Iborra I, Rubio J, Casanova JL, Ricos JV, Calabuig C. Prospective validation of the association of local tumour stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 2001; 165: 1506-9
3. Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int 2001; 88: 473-83
4. Slaton JW, Morgenstern N, Levy DA et al. Tumour stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol 2001; 165: 1138-42
5. Pizzocaro G, Piva L, Bandieramonte G, Tana S. Up-to-date management of carcinoma of the penis. Eur Urol 1997; 32: 5-15
6. Lopes A, Hidalgo GS, Kowallski LP, Torloni H, Rossi BM, Fonseca FP. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 1996; 156: 1637-42
7. Ficarra V, Martignoni G, Maffei N et al. Predictive pathological factors of lymph nodes involvement in squamous cell carcinoma of the penis. Int Urol Nephrol 2002; 34: 245-50
8. Stancik I, Holtl W. Penile cancer: review of recent literature. Curr Opin Urol 2003; 13: 467-72
9. Laniado ME, Lowdell C, Mitchell H, Christmas TJ. Squamous cell carcinoma antigen: a role in the early identification of nodal metastases in men with squamous cell carcinoma of the penis. BJU Int 2003; 92: 248-50
10. Maruo T, Yoshida S, Samoto T et al. Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix. Tumour Biol 1998; 19: 494-504
11. Petrelli NJ, Palmer M, Herrera L, Bhargava A. The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal. Cancer 1992; 70: 35-9
12. Wishnow KI, Johnson DE, Pritsche HA. Squamous cell carcinoma antigen in genitourinary tumors. Int J Biol Markers 1989; 4: 226-8
13. Tsukamoto T, Kumamoto Y, Ohmura K et al. Squamous cell carcinoma-associated antigen in uroepithelial carcinoma. Urology 1992; 40: 477-83
14. Jaeschke R, Guyatt GH, Sackett DL. Users' guide to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994; 271: 703-7
15. Wishnow KI, Johnson DE, Pritsche H. Squamous cell carcinoma antigen (TA-4) in penile carcinoma. Urology 1990; 36: 315-7